During the past decade, Martini-Klinik am UKE GmbH conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Martini-Klinik am UKE GmbH" #1 sponsor was "Martini-Klinik am UKE GmbH" with 5 trials, followed by "Pfizer" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Martini-Klinik am UKE GmbH" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator, "Eindhoven University of Technology" with 1 trials as a collaborator, "Erich und Gertrud Roggenbuck-Stiftung zur Förderung der Krebsforschung" with 1 trials as a collaborator and "Seirin Corporation, Shizuoka City, Japan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Martini-Klinik am UKE GmbH" are "Prostate Cancer" (8 trials), "Cancer of the Prostate" (1 trials), "Castration-Resistant Prostate Cancer" (1 trials), "Crohn's Disease" (1 trials) and "Indication for Prostate Biopsy Due to Suspected Prostate Cancer" (1 trials). Many other conditions were trialed in "Martini-Klinik am UKE GmbH" in a lesser frequency.

Most popular intervention types in "Martini-Klinik am UKE GmbH" are "Drug" (7 trials), "Diagnostic Test" (3 trials), "Other" (3 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Enzalutamide" (3 trials), "Acupressure" (1 trials), "Acupuncture" (1 trials) and "Androgen Deprivation Therapy (ADT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Martini-Klinik am UKE GmbH" are 13 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Martini-Klinik am UKE GmbH". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Martini-Klinik am UKE GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Martini-Klinik am UKE GmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

Martini-Klinik am UKE GmbH has several departments that took part in Clinical trials: "Martini-Klinik am UKE Hamburg-Eppendorf Prostate Cancer Center" - 2 trials